Actinium Pharmaceuticals (ATNM) Stock Chart & Stock Price History $1.60 -0.02 (-1.23%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$2.42 +0.83 (+51.56%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Actinium Pharmaceuticals Stock Price Performance The Actinium Pharmaceuticals (ATNM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 23.26%, with a year-to-date return of 26.98%. In the past month, the stock has increased 12.68%, reflecting recent market activity. As of the latest close, Actinium Pharmaceuticals traded at $1.60 with a market cap of $49.91 million and volume of 73,645 shares. Five years ago, the stock traded at a split-adjusted price of $0.43, representing a 272.09% increase over that period. At the time, it had a market cap of $158.54 million and a volume of 32.48 million shares. Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.62%1 Month Performance+12.68%3 Month Performance+14.29%Year-To-Date Performance+26.98%1 Year Performance-23.26%5 Year Performance+272.09% ATNM Stock Chart for Thursday, August, 7, 2025 ATNM Chart by TradingView Actinium Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025$1.62$1.60-1.23%$1.65$1.5973,645 shs$49.91 million08/05/2025$1.66$1.62-2.41%$1.66$1.6182,797 shs$50.54 million08/04/2025$1.61$1.66+3.11%$1.68$1.6288,784 shs$51.79 million08/01/2025$1.63$1.61-1.23%$1.68$1.57151,199 shs$50.23 million07/31/2025$1.57$1.63+3.82%$1.74$1.59604,376 shs$50.85 million07/30/2025$1.61$1.57-2.48%$1.74$1.54204,933 shs$48.98 million07/29/2025$1.72$1.61-6.40%$1.76$1.60193,017 shs$50.23 million07/28/2025$1.79$1.72-3.91%$1.79$1.70189,322 shs$53.66 million07/25/2025$1.82$1.79-1.65%$1.86$1.75147,234 shs$55.84 million07/24/2025$1.87$1.82-2.67%$1.87$1.75180,208 shs$56.78 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$1.82$1.87+2.75%$1.89$1.78282,779 shs$58.34 million07/22/2025$1.69$1.82+7.69%$1.84$1.63380,552 shs$56.78 million07/21/2025$1.71$1.69-1.17%$1.79$1.67334,352 shs$52.72 million07/18/2025$1.62$1.71+5.56%$1.77$1.63241,883 shs$53.35 million07/17/2025$1.59$1.62+1.89%$1.69$1.57340,884 shs$50.54 million07/16/2025$1.52$1.59+4.95%$1.61$1.50165,924 shs$49.60 million07/15/2025$1.57$1.52-3.50%$1.59$1.49200,242 shs$47.26 million07/14/2025$1.52$1.57+3.29%$1.57$1.48121,409 shs$48.98 million07/11/2025$1.55$1.52-1.94%$1.57$1.49203,660 shs$47.42 million07/10/2025$1.58$1.55-1.90%$1.63$1.54263,260 shs$48.35 million07/09/2025$1.43$1.58+10.49%$1.58$1.45267,205 shs$49.29 million07/08/2025$1.42$1.43+0.70%$1.49$1.40202,954 shs$44.61 million07/07/2025$1.44$1.42-1.39%$1.45$1.40184,325 shs$44.30 million Related Companies Neoleukin Therapeutics Stock Price Chart Caribou Biosciences Stock Price Chart 4D Molecular Therapeutics Stock Price Chart Alumis Stock Price Chart CARGO Therapeutics Stock Price Chart Instil Bio Stock Price Chart GENFIT Stock Price Chart Organigram Global Stock Price Chart Eupraxia Pharmaceuticals Stock Price Chart Semper Paratus Acquisition Stock Price Chart Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ATNM) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
